# Irinotecan hydrochloide

NDC: 68001-480
Generic name: Irinotecan hydrochloide
Labeler / Manufacturer: BluePoint Laboratories
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20201214

FDA application: ANDA212993

## Active ingredients

- IRINOTECAN HYDROCHLORIDE: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68001-480"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68001-480
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b66dbd6d-6ccb-ce9d-e053-2995a90a4c3c